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Letter to the Editor Harry L. Arnold Jr. MD
Case of the Month
Don Blake, APR
Public Relations
The Hemlock Society USA
The November issue of Hawai Medical Journal just reached my
desk. Congratulations on your continued fine work as editor.
By the way, I think your idea of adopting D.A.D,D. as a meaning
ful acronym is a good one. It is easy for the general public to
understand and accept, and it takes the harsh edge from the general
public image of physician-assisted death.
Thanks for your support as a national board member. Perhaps
we’ll have the occasion to meet when you are next in Denver or
elsewhere for a board function.
Military Medicine
Military Unique Curriculum
Benjamin W. Berg MD, LTC, U.S. Army
Graduate Medical education in the Military largely mirrors the
civilian sector. Educational standards, and program requirements as
prescribed by the Accreditation Council for Graduate Medical
Education (ACGME) are identical to civilian training programs.
The spectrum of programs available in the US Army is broad. There
are primary training programs in virtually all specialties, including
Family Practice, Internal Medicine, General Surgery, Pediatrics,
Psychiatry, Obstetrics and Gynecology, Radiology, and Pathology.
Advanced training in subspecialty areas is also available in some
fields, where research and clinical fellowships are established. In
recent years there has been a decrease in the Military GME pro
grams, as the overall size of the Military is decreased. Army GME
takes place largely at “Major Medical Centers” which are located in
Honolulu (Tripler), Washington D.C. (Walter Reed), San Antonio
(Brooke) and El Paso (William Beaumont) Texas, Tacoma Wash
ington (Madigan), and Augusta Georgia (Eisenhower). The
Fitzsimmons Army Medical Center in Denver, Colorado closed its
doors about 18 months ago.
Medical students apply for competitive residency training in Mili
tary Hospitals from either a Military sponsored civilian Medical
School, or from the Uniformed Services University of Health
Sciences (USUHS) which is located in Bethesda Maryland. The
Majority of applications for Military internships are from Civilian
Medical School applicants who have participated in the Health
Professions Scholarship Program (HPSP). These candidates have a
four year obligation to serve in the Uniformed Service of their
choice, after residency training is completed. The program provides
Continued on Page 386
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Introduction
Adult T-Cell Leukemia/Lymphoma is an aggressive form of
lymphoproliferative disease which is specifically caused by infec
tion with human T-cell lymphotropic virus type I (HTLV-I). Infec
tion with this virus is endemic in southwest Japan, the southeastern
United States, the Caribbean Islands, and central Africa.1 More
recently, genetically distinct forms of the virus have been identified
in Australian aboriginal tribes as well as various isolated popula
tions in Papua New Guinea and the Solomon Islands in Melanesia.2
However, evidence of infection with HTLV-I has not been iden
tified in Micronesian populations.3This is a report of a case ofAdult
T-Cell Leukemia in a Marshallese male medically evacuated to
Honolulu from the island of Majuro, Republic of the Marshall
Islands (RMI), which is in Pacific Micronesia. This case appears to
be the first report of a confirmed HTLV-I associated T-Cell Leuke
mia in a Micronesian patient.
Case Report
A 52-year-old Marshallese male was admitted to the hospital in
Majuro, RMI, because of generalized abdominal pain with disten
tion,jaundice, nausea, vomiting, subjective fever and chills, loss of
appetite, and shortness of breath.
Two weeks prior to admission, symptoms of nausea and vomiting,
diffuse abdominal pain, and loss of appetite began. He progressively
developed jaundice, increasing abdominal girth, and subjective
fever and chills. On examination, he was found to be jaundiced. His
abdomen was markedly distended with diffuse tenderness and
guarding but no peritoneal signs. Initial laboratory tests are shown
in Table 1. He was treated with Metronidazole 500mg P0 q8hrs,
Gentamycin 60mg IV q8hrs, Rocephin 1 gm IV q l2hrs, and Ampi
cillin 1 gm IV q6hrs for obstructive jaundice and ascending cholan
gitis. While hospitalized in Majuro, the patient’s white blood cell
count rose to 62,000, and after 5 days he was transferred to Honolulu
(Tripler Army Medical Center) for further evaluation.
The patient had a history of Hepatitis B infection twenty years
prior to admission and left nephrectomy for renal cell carcinoma
several years earlier. He was born and raised on the island of
Namodrik and lived there until the age of 16, at which time he
traveled to Majuro for three years to receive training as a “Health
Aide.” He frequently traveled to many of the neighboring islands
and atolls but had never traveled outside of Micronesia. He took no
medications and did not use tobacco or alcohol.
Examination revealed marked jaundice, hepatosplenomegaly,
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and diffuse adenopathy with cervical, supraclavicular, axillary, and
inguinal lymph nodes. There was bilateral leg edema extending to
the knees. Abdominal and chest computed tomographic (CT) scan
showed bilateral axillary, precarinal, anterior mediastinal, and me
senteric adenopathy as well as hepatosplenomegaly and moderate
ascites. Peripheral blood smear was suggestive of acute leukemia or
high grade lymphoma/leukemia (Fig 1). Peripheral blood flow
cytometry studies confirmed T-Cell Leukemia (Table 2). Western
Blot analysis confirmed HTLV-I infection. The patient was treated
with Zidovudine 200 mg P0 five times daily and Alpha-Interferon
10 million units SC daily.
The patient’s hospital course was characterized by progressive
multiple organ system failure including oliguria, anasarca, asterixis,
hyporeflexia, and lethargy. A lumbar puncture was performed
which revealed no evidence of central nervous system involvement
by the lymphoma or leukemia, or CNS infection. Lactulose therapy
for hepatic encephalopathy was initiated. The following day the
patient’s mental status improved and the white blood cell count
decreased to 50,000. On the fifth night of admission the patient’s
temperature rose to 100.7 F and Ceftazidime 1gm IV q8hrs was
administered. He developed an allergic reaction so the antibiotic
was changed to Imipenem 500 mg IV q6hrs. Administration of 4
liters per nasal canulae of oxygen was required to maintain 92%
saturation by pulse oximetry.
On the sixth hospital day AZT was discontinued because of
progressive elevation in liver enzymes and liver failure. By the
seventh day oliguria developed and IV Furosemide failed to increase
urine output. Low grade disseminated intravascular coagulopathy,
nonoliguric renal failure with creatinine increasing to 2.0 mg/dl, and
possible hepatorenal syndrome evolved and the patient became
progressively more somnolent. The patient decided not to continue
treatment and he died on the eleventh day of his admission. Despite
the development of multiorgan system failure his white blood cell
count reached a nadir of 23.5 x 1 0(9)1L and an absolute lymphocyte
count 18.1 x 10(9)/L with treatment.
Pathology
Examination of the patient’s admission hemogram and peripheral
smear disclosed normal red cell parameters and an atypical lympho
cytosis (white count 64,900; lymphocytes 90%) comprising moder
ately sized cells with immature chromatin, one to several variably
conspicuous nucleoli, and variably folded to overtly convoluted and
multilobulated nuclear configurations. Cytoplasm was scant to
moderate in quantity and non-granular. A conspicuous minority of
cells manifested a “hand-mirror” appearance (Fig 1) due to the
presence ofa cytoplasmic uropod. Platelets were decreased (60,000).
Bone marrow aspirate smears and core biopsy sections revealed
cellularity of 50% with a predominance of normal appearing he
matopoietic elements. Aspirate smears showed 30% and core bi
opsy sections 20% of nucleated cells to be lymphoid with immature
cytologic features and folded nuclear contours. In core biopsy
sections these lymphocytes formed aggregates which occupied non
paratrabecular foci.
Peripheral blood lymphocytes were studied by flow cytometric
analysis. Approximately 95% of lymphocytes manifested a mature
T helper cell phenotype and were Tdt negative (Table 2).
Bone marrow cytogenetics study disclosed chromosomal abnor
malities in 19 out of 20 cells examined, involving complex rear-
Table 1.—Lab Values In Majuro In Honolulu
White Blood Cell 52 x 10(9)/L 54.3 x 10(9)/I
Hemoglobin 14 g/dl 15 g/dl
Hematoct 39% 44%
Platelets 78 x 10(9)IL 66 x 10(9)/L
Absolute Granulocyte Count 8.32 x 10(9)/L 4.3 x 10(9)11..
Absolute Lymphocyte Count 42,1 x 10(0)/L 4.3 x 10(9)/I..
Prothrombin Time 13 seconds 19.6 seconds
Partila Thromboplastin Time 36 seconds 52 seconds
Total Protein 7.0 g/dl 6.7 gldl
Albumin 3.1 gldl 2,7 gldl
Aspartate Aminotrasferase 394 U/L 426/U/L
Alanine Aminotransferase 160 U/I 146
Alkaline Phosphatase 243 U/I 202 U/I
Total Bilirubin 9.4 mg/dl 15 mgldl
Table 2.—Peripheral Blood Flow Cytometry
Cell Markers Percentage of Cells Positive
CD2 96
CD3 94
CD4 92
CD5 95
CD7 4
CD8 2
Myeloperoxidase 2
Tdt 0
CD34 1
CD45 98
CD56 I
HL-DR 17
rangements of chromosomes 1,9, 12, and 15 [46, XY, del(9) (ql2),
der (12) t (1;12) (q21; q24), add (15)(q24)]. Peripheral blood
analysis disclosed a Western Blot pattern which was positive for
HTLV-I antibodies.
The aggregate of these findings was diagnostic of Adult T-Cell
Leukemia Lymphoma related to HTLV- I infection.
Discussion
Human T-cell lymphotropic virus type I (HTLV-I) is the first
human retrovirus isolated and one of the first viruses to be confirmed
as causing human cancer.4 In addition to adult T-Cell Leukemia/
Lymphoma it has been implicated in Tropical Spastic Paraparesis/
HTLV-I-Associated Myelopathy (TSPIHAM), a chronic, progres
sive degenerative disease of the spinal cord.5 Because the virus is
endemic in parts of Japan, T-Cell leukemia/lymphoma is the most
common type of lymphoma in that country.6The virus apparently
infects Cd4+ human T-cells and integrates its proviral DNA into the
cell’s own genome.7 There is genetic variability in viruses from
different geographical locations which does not appear to play a role
in the clinical presentation of the infection.8’9Major genetic differ
ences exist between viral isolates from Japan, Africa and Melanesia,
and the rare isolate from a Polynesian patient has been reported to
be virtually identical to the Japanese strain.2Prior reported cases of
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HTLV-I infection in Hawaii were associated with TSP/HAM and
occurred in Japanese-American patients whose parents had lived in
regions of Japan that were endemic for the virus.10 This patient
represents the first case reported in the English language medical
literature of HTLV-1 associated T-cell leukemia from Micronesia.
It is unclear how our patient acquired his HTLV-I infection. Since
HTLV- 1 is known to be transmitted by blood products, and contact
with body fluids he could have become infected at the same time as
his Hepatitis B was acquired. It is not certain how the patient
developed Hepatitis B, however, he denied blood transfusions, even
during his nephrectomy. During his work in the Marshall Islands the
patient was frequently exposed to blood products. Since HTLV-1
has not been previously documented in Marshallese patients, the
presumed extremely low prevalence of the virus in that population
makes it unlikely that he acquired it through occupational exposure.
Since much of the tertiary health care provided to the Micronesian
population occurs at various civilian and military medical institu
tions in Hawaii, all practitioners should be aware of this first case
from that region. While a rare disease, recent publications suggest
that significant palliation and even cure is possible with aggressive
chemoimmunotherapy using alpha-interferon and zidovudine.”
Investigation of seroprevalence rates of HTLV- 1 infection in the
Republic of the Marshall Islands and other Micronesian populations
may provide a window of opportunity to further elucidate the
mode(s) of transmission, infectivity, and carcinogenicity of this
retrovirus.
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Editor’s Note:
This is our first “Case of the Month.” This new
feature honors our late editor Harry L. Arnold Jr. MD.
Benjamin W. Berg MD will serve as editor and
facilitator for this new and unique series of case
reports from our Medical Ohana. Manuscripts for the
“Case of the Month” may be sent to LTC Benjamin
W. Berg, MC, Chief Pulmonary/Critical Care at
Tripler Army Medical Center, HI 96859 and a copy
to the Journal office.
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STRAU B WELCOMES
Thomas Van. MD
/
Straub is proud to
announce that
Dr. Thomas Van is now
practicing medicine at
the Straub Manoa Family
Health Center. Thomas TC. Van, MD
Family Practice -
Board Cert,:fied
Straub
When it really matters
Visa Ssnat,s homepage at htip Msns- strauhheallh oil,
MD at linirersily of
Toronto
Residency at Toronto
General Hospital
Finent in Cantonese and
I 7e1 no ,i,ese
Straub Manoa Family Health Center
1904 University Avenue, Honolulu, HI 96822 Phone: (808) 947-4646
Hours: Monday-Friday 8:00 a.m.—6:00 p.m., Saturday 8:00 a.m.—12 noon
HAWAII MEDICAL JOURNAL, VOL 57, JANUARY 1998
374
